{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:07:52Z","timestamp":1794496072576,"version":"4.9.1"},"publisher-location":"Berlin, Heidelberg","reference-count":301,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662446041","type":"print"},{"value":"9783662446058","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-662-44605-8_15","type":"book-chapter","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T04:49:24Z","timestamp":1428641364000},"page":"257-290","source":"Crossref","is-referenced-by-count":32,"title":["Antihistamines and Itch"],"prefix":"10.1007","author":[{"given":"Robin L.","family":"Thurmond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvan","family":"Kazerouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Chaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Greenspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62814-1","volume":"81","author":"MB Abelson","year":"1998","unstructured":"Abelson MB (1998) Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol 81:211\u2013218","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0149-2918(02)85045-7","volume":"24","author":"MB Abelson","year":"2002","unstructured":"Abelson MB, Kaplan AP (2002) A randomized, double-blind, placebo-controlled comparison of emedastine 0.05\u00a0% ophthalmic solution with loratadine 10\u00a0mg and their combination in the human conjunctival allergen challenge model. Clin Ther 24:445\u2013456","journal-title":"Clin Ther"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0420.1999.tb01175.x","volume":"228","author":"MB Abelson","year":"1999","unstructured":"Abelson MB, Lanier RQ (1999) The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model. Acta Ophthalmol Scand Suppl 228:53\u201356","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0161-6420(88)32980-5","volume":"95","author":"MB Abelson","year":"1988","unstructured":"Abelson MB, Smith LM (1988) Levocabastine. Evaluation in the histamine and compound 48\/80 models of ocular allergy in humans. Ophthalmology 95:1494\u20131497","journal-title":"Ophthalmology"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0420.2000.078s230060.x","volume":"230","author":"MB Abelson","year":"2000","unstructured":"Abelson MB, Welch DL (2000) An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1\u00a0%) compared to Claritin (loratadine 10\u00a0mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta Ophthalmol Scand Suppl 230:60\u201363","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9394(14)74864-0","volume":"90","author":"MB Abelson","year":"1980","unstructured":"Abelson MB, Allansmith MR, Friedlaender MH (1980) Effects of topically applied occular decongestant and antihistamine. Am J Ophthalmol 90:254\u2013257","journal-title":"Am J Ophthalmol"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0161-6420(95)31023-8","volume":"102","author":"MB Abelson","year":"1995","unstructured":"Abelson MB, George MA, Smith LM (1995) Evaluation of 0.05\u00a0% levocabastine versus 4\u00a0% sodium cromolyn in the allergen challenge model. Ophthalmology 102:310\u2013316","journal-title":"Ophthalmology"},{"key":"15_CR8","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.clinthera.2009.09.001","volume":"31","author":"MB Abelson","year":"2009","unstructured":"Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR (2009) Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0\u00a0% and 1.5\u00a0% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children. Clin Ther 31:1908\u20131921","journal-title":"Clin Ther"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2011.12.021","volume":"67","author":"K Ahern","year":"2012","unstructured":"Ahern K, Gilmore ES, Poligone B (2012) Pruritus in cutaneous T-cell lymphoma: a review. J Am Acad Dermatol 67:760\u2013768","journal-title":"J Am Acad Dermatol"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","volume":"118","author":"CA Akdis","year":"2006","unstructured":"Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung Donald YM, Lipozencic J, Luger Thomas A, Muraro A, Novak N, Platts-Mills Thomas AE, Rosenwasser L, Scheynius A, Simons FER, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152\u2013169","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/jm8005959","volume":"51","author":"RJ Altenbach","year":"2008","unstructured":"Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD (2008) Structure-activity studies on a series of 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 51:6571\u20136580","journal-title":"J Med Chem"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2133.2007.07796.x","volume":"156","author":"T Amano","year":"2007","unstructured":"Amano T, Takeda T, Yano H, Tamura T (2007) Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice. Br J Dermatol 156:906\u2013912","journal-title":"Br J Dermatol"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/82924","volume":"4","author":"D Andrew","year":"2001","unstructured":"Andrew D, Craig AD (2001) Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4:72\u201377","journal-title":"Nat Neurosci"},{"key":"15_CR14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1081-1206(10)60452-8","volume":"100","author":"R Anolik","year":"2008","unstructured":"Anolik R (2008) Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 100:264\u2013271","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00210-011-0704-0","volume":"385","author":"H Appl","year":"2012","unstructured":"Appl H, Holzammer T, Dove S, Haen E, Strasser A, Seifert R (2012) Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics. Naunyn Schmiedeberg\u2019s Arch Pharmacol 385:145\u2013170","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"15_CR16","doi-asserted-by":"crossref","unstructured":"Arnulf I (2009) Results of clinical trials of tiprolisant in narcolepsy and Parkinson\u2019s disease. In: 22nd ECNP congress p S.19.05, Istanbul, Turkey","DOI":"10.1016\/S0924-977X(09)70268-8"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1983) Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832\u2013837","journal-title":"Nature"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(85)90115-3","volume":"111","author":"JM Arrang","year":"1985","unstructured":"Arrang JM, Garbarg M, Tam TQ, My DTT, Yeramian E, Schwartz JC (1985) Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 111:73\u201384","journal-title":"Eur J Pharmacol"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1966.tb01674.x","volume":"27","author":"ASF Ash","year":"1966","unstructured":"Ash ASF, Schild JO (1966) Receptors mediating some action of histamine. Br J Pharmacol Chemother 27:427\u2013439","journal-title":"Br J Pharmacol Chemother"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1476-5381.1949.tb00529.x","volume":"4","author":"CA Ashford","year":"1949","unstructured":"Ashford CA, Heller H, Smart GA (1949) Effect of antihistamine substances on gastric secretion in man. Br J Pharmacol Chemother 4:157\u2013161","journal-title":"Br J Pharmacol Chemother"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1600-0625.2011.01268.x","volume":"20","author":"W Baeumer","year":"2011","unstructured":"Baeumer W, Stahl J, Sander K, Petersen LJ, Paps J, Stark H, Kietzmann M, Olivry T (2011) Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol 20:577\u2013581","journal-title":"Exp Dermatol"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","volume":"60","author":"RA Bakker","year":"2001","unstructured":"Bakker RA, Schoonus SBJ, Smit MJ, Timmerman H, Leurs R (2001) Histamine H1-receptor activation of nuclear factor-kB: roles for Gbg- and Gaq\/11-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60:1133\u20131142","journal-title":"Mol Pharmacol"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2013.05.001","volume":"132","author":"WT Barchuk","year":"2013","unstructured":"Barchuk WT, Salapatek AM, Ge T, D\u2019Angelo P, Liu X (2013) A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion. J Allergy Clin Immunol 132:838\u2013846.e836","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1039\/CT9109702592","volume":"97","author":"G Barger","year":"1910","unstructured":"Barger G, Dale HH (1910) 4-\u03b2-Aminoethylglyoxaline (\u03b2-Aminazolylethylamine) and the other active principles of ergot. J Chem Soc Trans 97:2592\u20132595","journal-title":"J Chem Soc Trans"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1398-9995.2008.01720.x","volume":"63","author":"W B\u00e4umer","year":"2008","unstructured":"B\u00e4umer W, Wendorff S, Gutzmer R, Werfel T, Dijkstra D, Chazot P, Stark H, Kietzmann M (2008) Histamine H4 receptors modulate dendritic cell migration through skin\u2014immunomodulatory role of histamine. Allergy 63:1387\u20131394","journal-title":"Allergy"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00210-011-0700-4","volume":"385","author":"S Beermann","year":"2012","unstructured":"Beermann S, Seifert R, Neumann D (2012) Commercially available antibodies against human and murine histamine H4-receptor lack specificity. Naunyn Schmiedeberg's Arch Pharmacol 385:125\u2013135","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"15_CR27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.bjp.0705754","volume":"142","author":"JK Bell","year":"2004","unstructured":"Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol 142:374\u2013380","journal-title":"Br J Pharmacol"},{"key":"15_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","volume":"104","author":"M Benninger","year":"2010","unstructured":"Benninger M, Farrar JR, Blaiss M, Chipps B, Ferguson B, Krouse J, Marple B, Storms W, Kaliner M (2010) Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol 104:13\u201329","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR29","first-page":"1404","volume":"86","author":"NV Bergasa","year":"1991","unstructured":"Bergasa NV, Jones EA (1991) Management of the pruritus of cholestasis: potential role of opiate antagonists. Am J Gastroenterol 86:1404\u20131412","journal-title":"Am J Gastroenterol"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62086-8","volume":"89","author":"WE Berger","year":"2002","unstructured":"Berger WE, Schenkel EJ, Mansfield LE (2002) Safety and efficacy of desloratadine 5\u00a0mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol 89:485\u2013491","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1081-1206(10)63041-4","volume":"79","author":"DI Bernstein","year":"1997","unstructured":"Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J (1997) Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 79:443\u2013448","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1113\/jphysiol.1927.sp002369","volume":"62","author":"CH Best","year":"1927","unstructured":"Best CH, Dale HH, Dudley HW, Thorpe WV (1927) The nature of the vaso-dilator constituents of certain tissue extracts. J Physiol 62:397\u2013417","journal-title":"J Physiol"},{"key":"15_CR33","first-page":"377","volume":"3","author":"RG Bickford","year":"1937","unstructured":"Bickford RG (1937) Experiments relating to the itch sensation, Its peripheral mechanism, and central pathways. Clin Sci 3:377\u2013386","journal-title":"Clin Sci"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","volume":"65","author":"L Bielory","year":"2005","unstructured":"Bielory L, Lien KW, Bigelsen S (2005) Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 65:215\u2013228","journal-title":"Drugs"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","volume":"236","author":"JW Black","year":"1972","unstructured":"Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM (1972) Definition and antagonism of histamine H2-receptors. Nature 236:385\u2013390","journal-title":"Nature"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/S0190-9622(03)01590-1","volume":"49","author":"P Bonadonna","year":"2003","unstructured":"Bonadonna P, Lombardi C, Senna G, Canonica GW, Passalacqua G, Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N (2003) Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 49:714\u2013716","journal-title":"J Am Acad Dermatol"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","volume":"87","author":"M Borazan","year":"2009","unstructured":"Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS (2009) Efficacy of olopatadine HCI 0.1\u00a0%, ketotifen fumarate 0.025\u00a0%, epinastine HCI 0.05\u00a0%, emedastine 0.05\u00a0% and fluorometholone acetate 0.1\u00a0% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. Acta Ophthalmol 87:549\u2013554","journal-title":"Acta Ophthalmol"},{"key":"15_CR38","first-page":"547","volume":"124","author":"D Bovet","year":"1937","unstructured":"Bovet D, Staub AM (1937) Protective action of some phenolic ethers in histamine intoxication. C R Seances Soc Biol Fil 124:547\u2013549","journal-title":"C R Seances Soc Biol Fil"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","volume":"30","author":"DL Breneman","year":"1996","unstructured":"Breneman DL (1996) Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 30:1075\u20131079","journal-title":"Ann Pharmacother"},{"key":"15_CR40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1113\/jphysiol.2007.139352","volume":"583","author":"E Breunig","year":"2007","unstructured":"Breunig E, Michel K, Zeller F, Seidl S, von Weyhern CWH, Schemann M (2007) Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol (Oxford, UK) 583:731\u2013742","journal-title":"J Physiol (Oxford, UK)"},{"key":"15_CR41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/1523-1747.ep12260955","volume":"82","author":"I Brody","year":"1984","unstructured":"Brody I (1984) Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. J Investig Dermatol 82:460\u2013464","journal-title":"J Investig Dermatol"},{"key":"15_CR42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1398-9995.1996.tb00092.x","volume":"51","author":"J Brostoff","year":"1996","unstructured":"Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P (1996) Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 51:320\u2013325","journal-title":"Allergy"},{"key":"15_CR43","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bjp.0705530","volume":"140","author":"KF Buckland","year":"2003","unstructured":"Buckland KF, Williams TJ, Conroy DM (2003) Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 140:1117\u20131127","journal-title":"Br J Pharmacol"},{"key":"15_CR44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4419-8056-4_8","volume":"709","author":"J Buddenkotte","year":"2010","unstructured":"Buddenkotte J, Maurer M, Steinhoff M (2010) Histamine and antihistamines in atopic dermatitis. Adv Exp Med Biol 709:73\u201380","journal-title":"Adv Exp Med Biol"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2500\/aap.2013.34.3671","volume":"34","author":"WW Carr","year":"2013","unstructured":"Carr WW, Nayak AS, Ratner PH, Gow JA, McNamara TR, Williams JI (2013) Efficacy of bepotastine besilate ophthalmic solution 1.5\u00a0% for seasonal allergic conjunctivitis: a randomized, placebo-controlled, natural exposure, clinical trial. Allergy Asthma Proc 34:247\u2013254","journal-title":"Allergy Asthma Proc"},{"key":"15_CR46","first-page":"284","volume":"21\u201322","author":"J Celice","year":"1942","unstructured":"Celice J, Perrault M, Durel P (1942) Utilisation clinique des antihistaminiques de synthese. Bull Mem Soc Med Hop Paris 21\u201322:284\u2013288","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"15_CR47","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1471-4159.1979.tb02276.x","volume":"32","author":"RSL Chang","year":"1979","unstructured":"Chang RSL, Vihn TT, Snyder SH (1979) Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes. J Neurochem 32:1653\u20131663","journal-title":"J Neurochem"},{"key":"15_CR48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2222.1997.tb00691.x","volume":"27","author":"G Ciprandi","year":"1997","unstructured":"Ciprandi G, Buscaglia S, Catrullo A, Pesce G, Fiorino N, Montagna P, Bagnasco M, Canonica GW (1997) Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity. Clin Exp Allergy 27:182\u2013191","journal-title":"Clin Exp Allergy"},{"key":"15_CR49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1034\/j.1398-9995.2001.00204.x","volume":"56","author":"GF Clough","year":"2001","unstructured":"Clough GF, Boutsiouki P, Church MK (2001) Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 56:985\u2013988","journal-title":"Allergy"},{"key":"15_CR50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/bj3550279","volume":"355","author":"F Coge","year":"2001","unstructured":"Coge F, Guenin S-P, Audinot V, Renouard-Try A, Beauverger P, Macia C, Ouvry C, Nagel N, Rique H, Boutin JA, Galizzi J-P (2001) Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J 355:279\u2013288","journal-title":"Biochem J"},{"key":"15_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1476-5381.2009.00227.x","volume":"157","author":"WM Connelly","year":"2009","unstructured":"Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RLM, Lees G, Chazot PL (2009) The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157:55\u201363","journal-title":"Br J Pharmacol"},{"key":"15_CR52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archderm.1954.01540140074006","volume":"69","author":"FE Cormia","year":"1954","unstructured":"Cormia FE, Kuykendall V (1954) Experimental histamine pruritus. III. Influence of drugs on the itch threshold. AMA Arch Derm Syphilol 69:206\u2013218","journal-title":"AMA Arch Derm Syphilol"},{"key":"15_CR53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2007.02.026","volume":"563","author":"G Coruzzi","year":"2007","unstructured":"Coruzzi G, Adami M, Guaita E, de Esch IJP, Leurs R (2007) Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 563:240\u2013244","journal-title":"Eur J Pharmacol"},{"key":"15_CR54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ddr.430230309","volume":"23","author":"PJ Coulie","year":"1991","unstructured":"Coulie PJ, Ghys L, Rihoux JP (1991) Histamine-induced wheal, flare, and pruritus: inhibition by cetirizine, terfenadine, and placebo. Drug Dev Res 23:269\u2013274","journal-title":"Drug Dev Res"},{"key":"15_CR55","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1021\/jm800670r","volume":"51","author":"MD Cowart","year":"2008","unstructured":"Cowart MD, Altenbach RJ, Liu H, Hsieh GC, Drizin I, Milicic I, Miller TR, Witte DG, Wishart N, Fix-Stenzel SR, McPherson MJ, Adair RM, Wetter JM, Bettencourt BM, Marsh KC, Sullivan JP, Honore P, Esbenshade TA, Brioni JD (2008) Rotationally constrained 2,4-Diamino-5,6-disubstituted pyrimidines: A new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 51:6547\u20136557","journal-title":"J Med Chem"},{"key":"15_CR56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/jid.2009.358","volume":"130","author":"JM Cowden","year":"2010","unstructured":"Cowden JM, Zhang M, Dunford PJ, Thurmond RL (2010) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Investig Dermatol 130:1023\u20131033","journal-title":"J Investig Dermatol"},{"key":"15_CR57","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0149-2918(02)80080-7","volume":"24","author":"HJ Crampton","year":"2002","unstructured":"Crampton HJ (2002) A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025\u00a0% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model. Clin Ther 24:1800\u20131808","journal-title":"Clin Ther"},{"key":"15_CR58","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0149-2918(03)80199-6","volume":"25","author":"HJ Crampton","year":"2003","unstructured":"Crampton HJ (2003) Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial. Clin Ther 25:1975\u20131987","journal-title":"Clin Ther"},{"key":"15_CR59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archderm.1945.01510280023003","volume":"52","author":"AC Curtis","year":"1945","unstructured":"Curtis AC, Owens BB (1945) Beta dimethylaminoethyl benzhydryl ether hydrochloride (benadryl) in treatment of urticaria. Arch Derm Syphilol 52:239\u2013242","journal-title":"Arch Derm Syphilol"},{"key":"15_CR60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0149-2918(02)85042-1","volume":"24","author":"PA D'Arienzo","year":"2002","unstructured":"D'Arienzo PA, Leonardi A, Bensch G (2002) Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05\u00a0% ophthalmic solution and ketotifen fumarate 0.025\u00a0% ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther 24:409\u2013416","journal-title":"Clin Ther"},{"key":"15_CR61","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1523-1747.2000.00193.x","volume":"115","author":"U Darsow","year":"2000","unstructured":"Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J (2000) Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Investig Dermatol 115:1029\u20131033","journal-title":"J Investig Dermatol"},{"key":"15_CR62","doi-asserted-by":"crossref","first-page":"10007","DOI":"10.1523\/JNEUROSCI.2862-07.2007","volume":"27","author":"S Davidson","year":"2007","unstructured":"Davidson S, Zhang X, Yoon CH, Khasabov SG, Simone DA, Giesler GJ Jr (2007) The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 27:10007\u201310014","journal-title":"J Neurosci"},{"key":"15_CR63","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nn.2292","volume":"12","author":"S Davidson","year":"2009","unstructured":"Davidson S, Zhang X, Khasabov SG, Simone DA, Giesler GJ Jr (2009) Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci 12:544\u2013546","journal-title":"Nat Neurosci"},{"key":"15_CR64","first-page":"461","volume":"9","author":"MG Davies","year":"1980","unstructured":"Davies MG, Greaves MW (1980) Sensory responses of human skin to synthetic histamine analogs and histamine. Br J Clin Pharmacol 9:461\u2013465","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00694619","volume":"266","author":"MG Davies","year":"1979","unstructured":"Davies MG, Marks R, Horton RJ, Storari FE (1979) The efficacy of histamine antagonists as antipruritics in experimentally induced pruritus. Arch Dermatol Res 266:117\u2013120","journal-title":"Arch Dermatol Res"},{"key":"15_CR66","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1006\/bbrc.1993.2662","volume":"197","author":"MD De Backer","year":"1993","unstructured":"De Backer MD, Gommeren W, Moereels H, Nobels G, Van Gompel P, Leysen JE, Luyten WHML (1993) Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem Biophys Res Commun 197:1601\u20131608","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR67","first-page":"265","volume":"58","author":"P Decourt","year":"1942","unstructured":"Decourt P (1942) Action de bases antagonistes de l'histamine sur quelques maladies liees a des reactions d'hypersensibilite. Bull Mem Soc Med Hop Paris 58:265\u2013266","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"15_CR68","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/mol.109.058651","volume":"76","author":"K-F Deml","year":"2009","unstructured":"Deml K-F, Beermann S, Neumann D, Strasser A, Seifert R (2009) Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor. Mol Pharmacol 76:1019\u20131030","journal-title":"Mol Pharmacol"},{"key":"15_CR69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00011-003-1193-5","volume":"52","author":"KJ Denham","year":"2003","unstructured":"Denham KJ, Boutsiouki P, Clough GF, Church MK (2003) Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 52:424\u2013427","journal-title":"Inflamm Res"},{"key":"15_CR70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1476-5381.2012.02049.x","volume":"167","author":"G Desmadryl","year":"2012","unstructured":"Desmadryl G, Gaboyard-Niay S, Brugeaud A, Travo C, Broussy A, Saleur A, Dyhrfjeld-Johnsen J, Wersinger E, Chabbert C (2012) Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability. Br J Pharmacol 167:905\u2013916","journal-title":"Br J Pharmacol"},{"key":"15_CR71","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.jid.5701250","volume":"128","author":"D Dijkstra","year":"2008","unstructured":"Dijkstra D, Stark H, Chazot PL, Shenton FC, Leurs R, Werfel T, Gutzmer R (2008) Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Investig Dermatol 128:1696\u20131703","journal-title":"J Investig Dermatol"},{"key":"15_CR72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0420.1999.tb01173.x","volume":"228","author":"M Discepola","year":"1999","unstructured":"Discepola M, Deschenes J, Abelson M (1999) Comparison of the topical ocular antiallergic efficacy of emedastine 0.05\u00a0% ophthalmic solution to ketorolac 0.5\u00a0% ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthalmol Scand Suppl 228:43\u201346","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"15_CR73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0304-3959(01)00271-8","volume":"92","author":"A Drzezga","year":"2001","unstructured":"Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, Weilke F, Ring J, Schwaiger M, Bartenstein P (2001) Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 92:295\u2013305","journal-title":"Pain"},{"key":"15_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1468-3083.1999.tb00802.x","volume":"12","author":"L Dubertret","year":"1999","unstructured":"Dubertret L, Murrieta Aguttes M, Tonet J (1999) Efficacy and safety of mizolastine 10\u00a0mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. J Eur Acad Dermatol Venereol 12:16\u201324","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"15_CR75","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.4049\/jimmunol.176.11.7062","volume":"176","author":"PJ Dunford","year":"2006","unstructured":"Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176:7062\u20137070","journal-title":"J Immunol"},{"key":"15_CR76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","volume":"119","author":"PJ Dunford","year":"2007","unstructured":"Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176\u2013183","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR77","first-page":"96","volume":"315","author":"A Eglezos","year":"1992","unstructured":"Eglezos A, Lecci A, Santicioli P, Giuliani S, Tramontana M, Del Bianco E, Maggi CA (1992) Activation of capsaicin-sensitive primary afferents in the rat urinary bladder by compound 48\/80: a direct action on sensory nerves? Arch Int Pharmacodyn Ther 315:96\u2013109","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"15_CR78","first-page":"1414","volume":"23","author":"H Eppinger","year":"1913","unstructured":"Eppinger H (1913) Wien Med Wochenschr 23:1414","journal-title":"Wien Med Wochenschr"},{"key":"15_CR79","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0026-895X(25)13286-0","volume":"44","author":"JC Eriks","year":"1993","unstructured":"Eriks JC, Van DGH, Timmerman H (1993) New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists. Mol Pharmacol 44:886\u2013894","journal-title":"Mol Pharmacol"},{"key":"15_CR80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.102.047183","volume":"305","author":"TA Esbenshade","year":"2003","unstructured":"Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA (2003) Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. J Pharmacol Exp Ther 305:887\u2013896","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR81","doi-asserted-by":"crossref","unstructured":"Fedorowicz Z, van Zuuren EJ, Hu N (2012) Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev 3:CD008596","DOI":"10.1002\/14651858.CD008596.pub2"},{"key":"15_CR82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","volume":"104","author":"AF Finn Jr","year":"1999","unstructured":"Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J (1999) A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 104:1071\u20131078","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2340\/0001555561245250","volume":"61","author":"B Fjellner","year":"1981","unstructured":"Fjellner B, Haegermark O (1981) Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 61:245\u2013250","journal-title":"Acta Derm Venereol"},{"key":"15_CR84","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555565409412","volume":"65","author":"B Fjellner","year":"1985","unstructured":"Fjellner B, Hagermark O (1985) Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta Derm Venereol 65:409\u2013412","journal-title":"Acta Derm Venereol"},{"key":"15_CR85","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-4362.1991.tb04360.x","volume":"30","author":"GC Francos","year":"1991","unstructured":"Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S, Burke JF Jr (1991) Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 30:884\u2013889","journal-title":"Int J Dermatol"},{"key":"15_CR86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(00)00110-9","volume":"25","author":"M Furue","year":"2001","unstructured":"Furue M, Terao H, Koga T (2001) Effects of Cetirizine and Epinastine on the skin response to histamine iontophoresis. J Dermatol Sci 25:59\u201363","journal-title":"J Dermatol Sci"},{"key":"15_CR87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2013.03.026","volume":"71","author":"N Galeotti","year":"2013","unstructured":"Galeotti N, Sanna MD, Ghelardini C (2013) Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology 71:141\u2013147","journal-title":"Neuropharmacology"},{"key":"15_CR88","first-page":"9","volume":"5","author":"AC Gallois-Bernos","year":"2012","unstructured":"Gallois-Bernos AC, Thurmond RL (2012) Alcaftadine, a new antihistamine with combined antagonist activity at histamine H1, H2, and H4 receptors. J Recept Ligand Channel Res 5:9\u201320","journal-title":"J. Recept Ligand Channel Res"},{"key":"15_CR89","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/0006-291X(91)91047-G","volume":"178","author":"I Gantz","year":"1991","unstructured":"Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, Yamada T (1991) Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 178:1386\u20131392","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR90","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.bjp.0706666","volume":"147","author":"F Gbahou","year":"2006","unstructured":"Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang J-M (2006) Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives. Br J Pharmacol 147:744\u2013754","journal-title":"Br J Pharmacol"},{"key":"15_CR91","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/mol.61.2.391","volume":"61","author":"M Gillard","year":"2002","unstructured":"Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P (2002) Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). Mol Pharmacol 61:391\u2013399","journal-title":"Mol Pharmacol"},{"key":"15_CR92","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1398-9995.2007.01330.x","volume":"62","author":"A Gimenez-Arnau","year":"2007","unstructured":"Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E (2007) Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 62:539\u2013546","journal-title":"Allergy"},{"key":"15_CR93","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","volume":"23","author":"A Gimenez-Arnau","year":"2009","unstructured":"Gimenez-Arnau A, Izquierdo I, Maurer M (2009) The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20\u00a0mg. J Eur Acad Dermatol Venereol 23:1088\u20131091","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"15_CR94","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2013.06.023","volume":"132","author":"F Glatzer","year":"2013","unstructured":"Glatzer F, Gschwandtner M, Ehling S, Rossbach K, Janik K, Klos A, Baeumer W, Kietzmann M, Werfel T, Gutzmer R (2013) Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J Allergy Clin Immunol 132:1358\u20131367","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR95","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1021\/jm030936t","volume":"46","author":"M Govoni","year":"2003","unstructured":"Govoni M, Bakker RA, van de Wetering I, Smit MJ, Menge WM, Timmerman H, Elz S, Schunack W, Leurs R (2003) Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists. J Med Chem 46:5812\u20135824","journal-title":"J Med Chem"},{"key":"15_CR96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI102414","volume":"30","author":"DT Graham","year":"1951","unstructured":"Graham DT, Goodell H, Wolff HG (1951) Neural mechanisms involved in itch, itchy skin, and tickle sensations. J Clin Investig 30:37\u201349","journal-title":"J Clin Investig"},{"key":"15_CR97","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199506293322608","volume":"332","author":"MW Greaves","year":"1995","unstructured":"Greaves MW (1995) Chronic urticaria. N Engl J Med 332:1767\u20131772","journal-title":"N Engl J Med"},{"key":"15_CR98","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0149-2918(03)80200-X","volume":"25","author":"JV Greiner","year":"2003","unstructured":"Greiner JV, Minno G (2003) A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Clin Ther 25:1988\u20132005","journal-title":"Clin Ther"},{"key":"15_CR99","first-page":"87","volume":"5","author":"JV Greiner","year":"2011","unstructured":"Greiner JV, Edwards-Swanson K, Ingerman A (2011) Evaluation of alcaftadine 0.25\u00a0% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1\u00a0%. Clin Ophthalmol 5:87\u201393","journal-title":"Clin Ophthalmol"},{"key":"15_CR100","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/jid.2011.72","volume":"131","author":"M Gschwandtner","year":"2011","unstructured":"Gschwandtner M, Mommert S, Koether B, Werfel T, Gutzmer R (2011a) The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Investig Dermatol 131:1668\u20131676","journal-title":"J Investig Dermatol"},{"key":"15_CR101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2567.2010.03336.x","volume":"132","author":"M Gschwandtner","year":"2011","unstructured":"Gschwandtner M, Schaekel K, Werfel T, Gutzmer R (2011b) Histamine H4 receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity. Immunology 132:49\u201356","journal-title":"Immunology"},{"key":"15_CR102","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2008.12.1110","volume":"123","author":"R Gutzmer","year":"2009","unstructured":"Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T (2009) The histamine H4 receptor is functionally expressed on TH2 cells. J Allergy Clin Immunol 123:619\u2013625","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR103","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2340\/0001555553363368","volume":"53","author":"O Hagermark","year":"1973","unstructured":"Hagermark O (1973) Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol 53:363\u2013368","journal-title":"Acta Derm Venereol"},{"key":"15_CR104","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12515092","volume":"71","author":"O Hagermark","year":"1978","unstructured":"Hagermark O, Hokfelt T, Pernow B (1978) Flare and itch induced by substance P in human skin. J Investig Dermatol 71:233\u2013235","journal-title":"J Investig Dermatol"},{"key":"15_CR105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2340\/0001555559297300","volume":"59","author":"O Hagermark","year":"1979","unstructured":"Hagermark O, Strandberg K, Gronneberg R (1979) Effects of histamine receptor antagonists on histamine-induced responses in human skin. Acta Derm Venereol 59:297\u2013300","journal-title":"Acta Derm Venereol"},{"key":"15_CR106","first-page":"339","volume":"68","author":"BN Halpern","year":"1942","unstructured":"Halpern BN (1942) Synthetic antihistamine substances. Arch Int Pharmacodyn Ther 68:339\u2013408","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"15_CR107","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nn.3289","volume":"16","author":"L Han","year":"2013","unstructured":"Han L, Ma C, Liu Q, Weng H-J, Cui Y, Tang Z, Kim Y, Nie H, Qu L, Patel KN, Li Z, McNeil B, He S, Guan Y, Xiao B, LaMotte RH, Dong X (2013) A subpopulation of nociceptors specifically linked to itch. Nat Neurosci 16:174\u2013182","journal-title":"Nat Neurosci"},{"key":"15_CR108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1152\/jn.1991.66.1.307","volume":"66","author":"HO Handwerker","year":"1991","unstructured":"Handwerker HO, Forster C, Kirchhoff C (1991) Discharge patterns of human C-fibers induced by itching and burning stimuli. J Neurophysiol 66:307\u2013315","journal-title":"J Neurophysiol"},{"key":"15_CR109","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0006-2952(83)90339-8","volume":"32","author":"M Harada","year":"1983","unstructured":"Harada M, Terai M, Maeno H (1983) Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig. Biochem Pharmacol 32:1635\u20131640","journal-title":"Biochem Pharmacol"},{"key":"15_CR110","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0091-6749(86)90230-7","volume":"78","author":"TE Havas","year":"1986","unstructured":"Havas TE, Cole P, Parker L, Oprysk D, Ayiomamitis A (1986) The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation. J Allergy Clin Immunol 78:856\u2013860","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR111","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1152\/jn.00475.2007","volume":"98","author":"L Herde","year":"2007","unstructured":"Herde L, Forster C, Strupf M, Handwerker HO (2007) Itch induced by a novel method leads to limbic deactivations a functional MRI study. J Neurophysiol 98:2347\u20132356","journal-title":"J Neurophysiol"},{"key":"15_CR112","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-4362.1975.tb04281.x","volume":"14","author":"JH Herndon Jr","year":"1975","unstructured":"Herndon JH Jr (1975) Itching: the pathophysiology of pruritus. Int J Dermatol 14:465\u2013484","journal-title":"Int J Dermatol"},{"key":"15_CR113","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.4088\/JCP.11m07178","volume":"73","author":"WJ Herring","year":"2012","unstructured":"Herring WJ, Wilens TE, Adler LA, Baranak C, Liu K, Snavely DB, Lines CR, Michelson D (2012) Randomized controlled study of the histamine h3 inverse agonist mk-0249 in adult attention-deficit\/hyperactivity disorder. J Clin Psychiatry 73:e891\u2013e898","journal-title":"J Clin Psychiatry"},{"key":"15_CR114","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.1995.tb02586.x","volume":"50","author":"O Hilberg","year":"1995","unstructured":"Hilberg O (1995) Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 50:683\u2013688","journal-title":"Allergy"},{"key":"15_CR115","first-page":"379","volume":"48","author":"F Horak","year":"1998","unstructured":"Horak F, Berger UE, Menapace R, Toth J, Stubner PU, Marks B (1998) Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Arzneimittelforschung 48:379\u2013384","journal-title":"Arzneimittelforschung"},{"key":"15_CR116","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0091-6749(96)70165-3","volume":"98","author":"L Horsmanheimo","year":"1996","unstructured":"Horsmanheimo L, Harvima IT, Harvima RJ, Brummer-Korvenkontio H, Francois G, Reunala T (1996) Histamine and leukotriene C4 release in cutaneous mosquito-bite reactions. J Allergy Clin Immunol 98:408\u2013411","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR117","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pain.2006.06.003","volume":"126","author":"M Hosogi","year":"2006","unstructured":"Hosogi M, Schmelz M, Miyachi Y, Ikoma A (2006) Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch. Pain 126:16\u201323","journal-title":"Pain"},{"key":"15_CR118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2133.2003.05341.x","volume":"149","author":"MA Hossen","year":"2003","unstructured":"Hossen MA, Sugimoto Y, Kayasuga R, Kamei C (2003) Involvement of histamine H3 receptors in scratching behavior in mast cell-deficient mice. Br J Dermatol 149:17\u201322","journal-title":"Br J Dermatol"},{"key":"15_CR119","first-page":"297","volume":"100","author":"MA Hossen","year":"2006","unstructured":"Hossen MA, Inoue T, Shinmei Y, Fujii Y, Watanabe T, Kamei C (2006) Role of substance P on histamine H3 antagonist-induced scratching behavior in mice. J Pharmacol Sci (Tokyo, Japan) 100:297\u2013302","journal-title":"J Pharmacol Sci (Tokyo, Japan)"},{"key":"15_CR120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","volume":"104","author":"PH Howarth","year":"1999","unstructured":"Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J (1999) Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180\u00a0mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol 104:927\u2013933","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR121","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1152\/jn.1994.72.6.3004","volume":"72","author":"JC Hsieh","year":"1994","unstructured":"Hsieh JC, Hagermark O, Stahle-Backdahl M, Ericson K, Eriksson L, Stone-Elander S, Ingvar M (1994) Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 72:3004\u20133008","journal-title":"J Neurophysiol"},{"key":"15_CR122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2009.12.004","volume":"95","author":"GC Hsieh","year":"2010","unstructured":"Hsieh GC, Chandran P, Salyers AK, Pai M, Zhu CZ, Wensink EJ, Witte DG, Miller TR, Mikusa JP, Baker SJ, Wetter JM, Marsh KC, Hancock AA, Cowart MD, Esbenshade TA, Brioni JD, Honore P (2010) H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 95:41\u201350","journal-title":"Pharmacol Biochem Behav"},{"key":"15_CR123","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/clpt.2010.205","volume":"88","author":"R Iannone","year":"2010","unstructured":"Iannone R, Palcza J, Renger JJ, Calder N, Cerchio K, Gottesdiener K, Hargreaves R, Dijk DJ, Boyle J, Murphy MG (2010) Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers. Clin Pharmacol Ther (NewYork, USA) 88:831\u2013839","journal-title":"Clin Pharmacol Ther (NewYork, USA)"},{"key":"15_CR124","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2131\/jts.33.503","volume":"33","author":"Y Ikawa","year":"2008","unstructured":"Ikawa Y, Shiba K, Ohki E, Mutoh N, Suzuki M, Sato H, Ueno K (2008) Comparative study of histamine H4 receptor expression in human dermal fibroblasts. J Toxicol Sci 33:503\u2013508","journal-title":"J Toxicol Sci"},{"key":"15_CR125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1254\/jphs.09R05FM","volume":"110","author":"A Ikoma","year":"2009","unstructured":"Ikoma A (2009) Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis. J Pharmacol Sci 110:265\u2013269","journal-title":"J Pharmacol Sci"},{"key":"15_CR126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/WNF.0b013e318246879d","volume":"35","author":"C Inocente","year":"2012","unstructured":"Inocente C, Arnulf I, Bastuji H, Thibault-Stoll A, Raoux A, Reimao R, Lin J-S, Franco P (2012) Pitolisant, an inverse agonist of the histamine H3 receptor: An alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol 35:55\u201360","journal-title":"Clin Neuropharmacol"},{"key":"15_CR127","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1523\/JNEUROSCI.1249-07.2007","volume":"27","author":"LM Johanek","year":"2007","unstructured":"Johanek LM, Meyer RA, Hartke T, Hobelmann JG, Maine DN, LaMotte RH, Ringkamp M (2007) Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci 27:7490\u20137497","journal-title":"J Neurosci"},{"key":"15_CR128","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1523\/JNEUROSCI.1760-08.2008","volume":"28","author":"LM Johanek","year":"2008","unstructured":"Johanek LM, Meyer RA, Friedman RM, Greenquist KW, Shim B, Borzan J, Hartke T, LaMotte RH, Ringkamp M (2008) A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci 28:7659\u20137669","journal-title":"J Neurosci"},{"key":"15_CR129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/jid.1960.38","volume":"34","author":"HH Johnson Jr","year":"1960","unstructured":"Johnson HH Jr, DeOreo GA, Lascheid WP, Mitchell F (1960) Skin histamine levels in chronic atopic dermatitis. J Investig Dermatol 34:237\u2013238","journal-title":"J Investig Dermatol"},{"key":"15_CR130","first-page":"383","volume":"47","author":"L Juhlin","year":"1967","unstructured":"Juhlin L (1967) Localization and content of histamine in normal and diseased skin. Acta Derm Venereol 47:383\u2013391","journal-title":"Acta Derm Venereol"},{"key":"15_CR131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09546630310018077","volume":"15","author":"L Juhlin","year":"2004","unstructured":"Juhlin L (2004) Inhibition of cold urticaria by desloratadine. J Dermatolog Treat 15:51\u201359","journal-title":"J Dermatolog Treat"},{"key":"15_CR132","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.02.001","volume":"70","author":"K Kabashima","year":"2013","unstructured":"Kabashima K (2013) New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 70:3\u201311","journal-title":"J Dermatol Sci"},{"key":"15_CR133","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2133.2007.08060.x","volume":"157","author":"Y Kameyoshi","year":"2007","unstructured":"Kameyoshi Y, Tanaka T, Mihara S, Takahagi S, Niimi N, Hide M (2007) Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients. Br J Dermatol 157:803\u2013804","journal-title":"Br J Dermatol"},{"key":"15_CR134","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/jid.2013.351","volume":"134","author":"A Kamo","year":"2014","unstructured":"Kamo A, Negi O, Tengara S, Kamata Y, Noguchi A, Ogawa H, Tominaga M, Takamori K (2014) Histamine H4 receptor antagonists ineffective against itch and skin inflammation in atopic dermatitis mouse model. J Investig Dermatol 134:546\u2013548","journal-title":"J Investig Dermatol"},{"key":"15_CR135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11882-002-0046-6","volume":"2","author":"AP Kaplan","year":"2002","unstructured":"Kaplan AP (2002) Chronic urticaria\u2013new concepts regarding pathogenesis and treatment. Curr Allergy Asthma Rep 2:263\u2013264","journal-title":"Curr Allergy Asthma Rep"},{"key":"15_CR136","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0091-6749(78)90113-6","volume":"61","author":"AP Kaplan","year":"1978","unstructured":"Kaplan AP, Horakova Z, Katz SI (1978) Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 61:350\u2013354","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR137","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S1081-1206(10)61325-7","volume":"94","author":"AP Kaplan","year":"2005","unstructured":"Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G (2005) Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 94:662\u2013669","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR138","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2340\/0001555580117121","volume":"80","author":"A Karppinen","year":"2000","unstructured":"Karppinen A, Petman L, Jekunen A, Kautiainen H, Vaalasti A, Reunala T (2000) Treatment of mosquito bites with ebastine: a field trial. Acta Derm Venereol 80:114\u2013116","journal-title":"Acta Derm Venereol"},{"key":"15_CR139","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2340\/00015555-0085","volume":"86","author":"A Karppinen","year":"2006","unstructured":"Karppinen A, Brummer-Korvenkontio H, Petman L, Kautiainen H, Herve J-P, Reunala T (2006) Levocetirizine for treatment of immediate and delayed mosquito bite reactions. Acta Derm Venereol 86:329\u2013331","journal-title":"Acta Derm Venereol"},{"key":"15_CR140","first-page":"1116","volume":"47","author":"M Kato","year":"1997","unstructured":"Kato M, Nishida A, Aga Y, Kita J, Kudo Y, Narita H, Endo T (1997) Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent bepotastine besilate. Arzneimittelforschung 47:1116\u20131124","journal-title":"Arzneimittelforschung"},{"key":"15_CR141","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2133.1998.02172.x","volume":"138","author":"GM Kavanagh","year":"1998","unstructured":"Kavanagh GM, Sabroe RA, Greaves MW, Archer CB (1998) The intradermal effects of the H3 receptor agonist R \u03b1 methylhistamine in human skin. Br J Dermatol 138:622\u2013626","journal-title":"Br J Dermatol"},{"key":"15_CR142","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2500\/aap.2008.29.3151","volume":"29","author":"DA Khan","year":"2008","unstructured":"Khan DA (2008) Chronic urticaria: diagnosis and management. Allergy Asthma Proc 29:439\u2013446","journal-title":"Allergy Asthma Proc"},{"key":"15_CR143","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1081-1206(10)60914-3","volume":"96","author":"K Kim","year":"2006","unstructured":"Kim K, Sussman G, Hebert J, Lumry W, Lutsky B, Gates D (2006) Desloratadine therapy for symptoms associated with perennial allergic rhinitis. Ann Allergy Asthma Immunol 96:460\u2013465","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1398-9995.1982.tb01897.x","volume":"37","author":"J Kirkegaard","year":"1982","unstructured":"Kirkegaard J, Secher C, Mygind N (1982) Effect of the H1 antihistamine chlorpheniramine maleate on histamine-induced symptoms in the human conjunctiva. Indirect evidence for nervous H1 receptors. Allergy 37:203\u2013208","journal-title":"Allergy"},{"key":"15_CR145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0007-0971(83)90017-7","volume":"77","author":"J Kirkegaard","year":"1983","unstructured":"Kirkegaard J, Secher C, Borum P, Mygind N (1983) Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: demonstration of topical effect. Br J Dis Chest 77:113\u2013122","journal-title":"Br J Dis Chest"},{"key":"15_CR146","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archderm.135.12.1522","volume":"135","author":"PA Klein","year":"1999","unstructured":"Klein PA, Clark RAF (1999) An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 135:1522\u20131525","journal-title":"Arch Dermatol"},{"key":"15_CR147","first-page":"432","volume":"20","author":"GA Koelsche","year":"1945","unstructured":"Koelsche GA, Prickman LE, Carryer HM (1945) The symptomatic treatment of bronchial asthma and hay fever with benadryl. Proc Staff Meet Mayo Clin 20:432","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"15_CR148","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.114.215749","volume":"350","author":"A Kollmeier","year":"2014","unstructured":"Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond R (2014) The H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 350:181\u2013187","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR149","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/all.12171","volume":"68","author":"K Krause","year":"2013","unstructured":"Krause K, Spohr A, Zuberbier T, Church MK, Maurer M (2013) Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 68:921\u2013928","journal-title":"Allergy"},{"key":"15_CR150","first-page":"345","volume":"50","author":"W Kreutner","year":"2000","unstructured":"Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S (2000) Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung 50:345\u2013352","journal-title":"Arzneimittelforschung"},{"key":"15_CR151","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/1523-1747.ep12337620","volume":"109","author":"AL Krogstad","year":"1997","unstructured":"Krogstad AL, Lonnroth P, Larson G, Wallin BG (1997) Increased interstitial histamine concentration in the psoriatic plaque. J Investig Dermatol 109:632\u2013635","journal-title":"J Investig Dermatol"},{"key":"15_CR152","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1517\/13543784.2011.625010","volume":"20","author":"S Kuhne","year":"2011","unstructured":"Kuhne S, Wijtmans M, Lim HD, Leurs R, de Esch IJP (2011) Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? Exp Opin Investig Drugs 20:1629\u20131648","journal-title":"Exp Opin Investig Drugs"},{"key":"15_CR153","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1365-2222.2009.03257.x","volume":"39","author":"P Kuna","year":"2009","unstructured":"Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R (2009) Efficacy and safety of bilastine 20\u00a0mg compared with cetirizine 10\u00a0mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. Clin Exp Allergy 39:1338\u20131347","journal-title":"Clin Exp Allergy"},{"key":"15_CR154","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2500\/aap.2007.28.3064","volume":"28","author":"M Kupczyk","year":"2007","unstructured":"Kupczyk M, Kuprys I, Bochenska-Marciniak M, Gorski P, Kuna P (2007) Ranitidine (150\u00a0mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc 28:711\u2013715","journal-title":"Allergy Asthma Proc"},{"key":"15_CR155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1081-1206(10)61468-8","volume":"93","author":"CF LaForce","year":"2004","unstructured":"LaForce CF, Corren J, Wheeler WJ, Berger WE (2004) Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol 93:154\u2013159","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR156","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2340\/0001555573350351","volume":"73","author":"A Lahti","year":"1993","unstructured":"Lahti A, Haapaniemi T (1993) Initiation of the effects of acrivastine and cetirizine on histamine-induced wheals and itch in human skin. Acta Derm Venereol 73:350\u2013351","journal-title":"Acta Derm Venereol"},{"key":"15_CR157","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1185\/030079904125004330","volume":"20","author":"BQ Lanier","year":"2004","unstructured":"Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL (2004) Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model. Curr Med Res Opin 20:1227\u20131233","journal-title":"Curr Med Res Opin"},{"key":"15_CR158","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1152\/jn.00070.2006","volume":"97","author":"SG Leknes","year":"2007","unstructured":"Leknes SG, Bantick S, Willis CM, Wilkinson JD, Wise RG, Tracey I (2007) Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J Neurophysiol 97:415\u2013422","journal-title":"J Neurophysiol"},{"key":"15_CR159","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1476-5381.1994.tb13157.x","volume":"112","author":"R Leurs","year":"1994","unstructured":"Leurs R, Smit MJ, Menge WM, Timmerman H (1994a) Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol 112:847\u2013854","journal-title":"Br J Pharmacol"},{"key":"15_CR160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/bbrc.1994.1701","volume":"201","author":"R Leurs","year":"1994","unstructured":"Leurs R, Smit MJ, Tensen CP, Ter Laak AM, Timmerman H (1994b) Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. Biochem Biophys Res Commun 201:295\u2013301","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR161","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1476-5381.1995.tb15071.x","volume":"116","author":"R Leurs","year":"1995","unstructured":"Leurs R, Tulp MTM, Menge WMBP, Adolfs MJP, Zuiderveld OP, Timmerman H (1995) Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Br J Pharmacol 116:2315\u20132321","journal-title":"Br J Pharmacol"},{"key":"15_CR162","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00544062","volume":"28","author":"S Levander","year":"1985","unstructured":"Levander S, Haegermark O, Staahle M (1985) Peripheral antihistamine and central sedative effects of three H1-receptor antagonists. Eur J Clin Pharmacol 28:523\u2013529","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR163","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00626365","volume":"41","author":"S Levander","year":"1991","unstructured":"Levander S, Staahle-Baeckdahl M, Haegermark O (1991) Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol 41:435\u2013439","journal-title":"Eur J Clin Pharmacol"},{"key":"15_CR164","volume-title":"The blood vessels of the human skin and their responses","author":"T Lewis","year":"1927","unstructured":"Lewis T (1927) The blood vessels of the human skin and their responses. Shaw and Sons, London"},{"key":"15_CR165","unstructured":"Lewis T (1942) Pain. The Macmillan Company, New York."},{"key":"15_CR166","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","volume":"320","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC (2007) BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther 320:365\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR167","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/jpet.105.087965","volume":"314","author":"HD Lim","year":"2005","unstructured":"Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310\u20131321","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR168","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0196-0644(00)43749-2","volume":"36","author":"RY Lin","year":"2000","unstructured":"Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, Tenenbaum C, Westfal RE (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36:462\u2013468","journal-title":"Ann Emerg Med"},{"key":"15_CR169","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","volume":"30","author":"JS Lin","year":"2008","unstructured":"Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC (2008) An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2212\/\u2212 mice and patients. Neurobiol Dis 30:74\u201383","journal-title":"Neurobiol Dis"},{"key":"15_CR170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0705729","volume":"142","author":"P Ling","year":"2004","unstructured":"Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung W-P (2004) Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol 142:161\u2013171","journal-title":"Br J Pharmacol"},{"key":"15_CR171","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1124\/mol.59.3.420","volume":"59","author":"C Liu","year":"2001","unstructured":"Liu C, Ma X-J, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001a) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420\u2013426","journal-title":"Mol Pharmacol"},{"key":"15_CR172","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3565(24)29309-5","volume":"299","author":"C Liu","year":"2001","unstructured":"Liu C, Wilson SJ, Kuei C, Lovenberg TW (2001b) Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 299:121\u2013130","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR173","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","volume":"55","author":"TW Lovenberg","year":"1999","unstructured":"Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG (1999) Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55:1101\u20131107","journal-title":"Mol Pharmacol"},{"key":"15_CR174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1081-1206(10)60663-1","volume":"99","author":"W Lumry","year":"2007","unstructured":"Lumry W, Prenner B, Corren J, Wheeler W (2007) Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Ann Allergy Asthma Immunol 99:267\u2013272","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2010.02.007","volume":"150","author":"TT Macejko","year":"2010","unstructured":"Macejko TT, Bergmann MT, Williams JI, Gow JA, Gomes PJ, McNamara TR, Abelson MB (2010) Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0\u00a0% and 1.5\u00a0% to treat allergic conjunctivitis. Am J Ophthalmol 150:122\u2013127","journal-title":"Am J Ophthalmol"},{"key":"15_CR176","first-page":"1465","volume":"62","author":"M Magerl","year":"2007","unstructured":"Magerl M, Schmolke J, Siebenhaar F, Zuberbier T, Metz M, Maurer M (2007) Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy (Oxford, UK) 62:1465\u20131468","journal-title":"Allergy (Oxford, UK)"},{"key":"15_CR177","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1185\/030079907X188206","volume":"23","author":"FS Mah","year":"2007","unstructured":"Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G (2007) Efficacy and comfort of olopatadine 0.2\u00a0% versus epinastine 0.05\u00a0% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge. Curr Med Res Opin 23:1445\u20131452","journal-title":"Curr Med Res Opin"},{"key":"15_CR178","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2125.1977.tb00725.x","volume":"4","author":"R Marks","year":"1977","unstructured":"Marks R, Greaves MW (1977) Vascular reactions to histamine and compound 48\/80 in human skin: suppression by a histamine H2-receptor blocking agent. Br J Clin Pharmacol 4:367\u2013369","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR179","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1600-0625.2012.01559.x","volume":"21","author":"A Matsushita","year":"2012","unstructured":"Matsushita A, Seike M, Okawa H, Kadawaki Y, Ohtsu H (2012) Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 21:714\u2013715","journal-title":"Exp Dermatol"},{"key":"15_CR180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.2003.01458.x","volume":"17","author":"M Mela","year":"2003","unstructured":"Mela M, Mancuso A, Burroughs AK (2003) Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 17:857\u2013870","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR181","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1081-1206(10)61025-3","volume":"95","author":"EO Meltzer","year":"2005","unstructured":"Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF Jr, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR (2005) Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95:600\u2013606","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR182","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","volume":"280","author":"M Merlos","year":"1997","unstructured":"Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, Garcia-Rafanell J, Forn J (1997) Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 280:114\u2013121","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR183","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2340\/00015555-0789","volume":"90","author":"N Meyer","year":"2010","unstructured":"Meyer N, Paul C, Misery L (2010) Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat. Acta Derm Venereol 90:12\u201317","journal-title":"Acta Derm Venereol"},{"key":"15_CR184","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0091-6749(85)90761-4","volume":"76","author":"RH Meyrick-Thomas","year":"1985","unstructured":"Meyrick-Thomas RH, Browne PD, Kirby JDT (1985a) The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reactions in human skin. J Allergy Clin Immunol 76:864\u2013869","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2125.1985.tb05080.x","volume":"20","author":"RH Meyrick-Thomas","year":"1985","unstructured":"Meyrick-Thomas RH, Browne PD, Kirby JDT (1985b) The influence of ranitidine, alone and in combination with clemastine, on histamine-mediated cutaneous weal and flare reactions in human skin. Br J Clin Pharmacol 20:377\u2013382","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR186","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/ajrccm\/136.2.357","volume":"136","author":"A Miadonna","year":"1987","unstructured":"Miadonna A, Tedeschi A, Leggieri E, Lorini M, Folco G, Sala A, Qualizza R, Froldi M, Zanussi C (1987) Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 136:357\u2013362","journal-title":"Am Rev Respir Dis"},{"key":"15_CR187","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(03)00249-5","volume":"105","author":"H Mochizuki","year":"2003","unstructured":"Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K (2003) Imaging of central itch modulation in the human brain using positron emission tomography. Pain 105:339\u2013346","journal-title":"Pain"},{"key":"15_CR188","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuroimage.2007.04.003","volume":"36","author":"H Mochizuki","year":"2007","unstructured":"Mochizuki H, Sadato N, Saito DN, Toyoda H, Tashiro M, Okamura N, Yanai K (2007) Neural correlates of perceptual difference between itching and pain: a human fMRI study. Neuroimage 36:706\u2013717","journal-title":"Neuroimage"},{"key":"15_CR189","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajpath.2011.09.028","volume":"180","author":"S Mommert","year":"2012","unstructured":"Mommert S, Gschwandtner M, Koether B, Gutzmer R, Werfel T (2012) Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol 180:177\u2013185","journal-title":"Am J Pathol"},{"key":"15_CR190","first-page":"17","volume":"14","author":"EW Monroe","year":"1992","unstructured":"Monroe EW (1992) Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Clin Ther 14:17\u201321","journal-title":"Clin Ther"},{"key":"15_CR191","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mjd.2003.143","volume":"48","author":"E Monroe","year":"2003","unstructured":"Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D (2003) Efficacy and safety of desloratadine 5\u00a0mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 48:535\u2013541","journal-title":"J Am Acad Dermatol"},{"key":"15_CR192","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1346-8138.2005.tb00716.x","volume":"32","author":"E Morita","year":"2005","unstructured":"Morita E, Matsuo H, Zhang Y (2005) Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: Suppressive effects on skin response to histamine iontophoresis. J Dermatol 32:58\u201361","journal-title":"J Dermatol"},{"key":"15_CR193","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(24)38851-2","volume":"296","author":"KL Morse","year":"2001","unstructured":"Morse KL, Behan J, Laz TM, West RE Jr, Greenfeder SA, Anthes JC, Umland S, Wan Y, Hipkin RW, Gonsiorek W, Shin N, Gustafson EL, Qiao X, Wang S, Hedrick JA, Greene J, Bayne M, Monsma FJ Jr (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296:1058\u20131066","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR194","first-page":"391","volume":"23","author":"JJ Murray","year":"2002","unstructured":"Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B (2002) Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 23:391\u2013398","journal-title":"Allergy Asthma Proc"},{"key":"15_CR195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0091-6749(82)90036-7","volume":"70","author":"N Mygind","year":"1982","unstructured":"Mygind N (1982) Mediators of nasal allergy. J Allergy Clin Immunol 70:149\u2013159","journal-title":"J Allergy Clin Immunol"},{"issue":"Pt 1","key":"15_CR196","first-page":"16","volume":"128","author":"N Mygind","year":"1983","unstructured":"Mygind N, Secher C, Kirkegaard J (1983) Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl 128(Pt 1):16\u201320","journal-title":"Eur J Respir Dis Suppl"},{"issue":"Suppl 2","key":"15_CR197","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2222.1991.tb01753.x","volume":"21","author":"RM Naclerio","year":"1991","unstructured":"Naclerio RM, Togias AG (1991) The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy 21(Suppl 2):13\u201319","journal-title":"Clin Exp Allergy"},{"key":"15_CR198","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/bbrc.2000.4008","volume":"279","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K (2000) Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 279:615\u2013620","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR199","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.02.035","volume":"608","author":"Y Nakano","year":"2009","unstructured":"Nakano Y, Takahashi Y, Ono R, Kurata Y, Kagawa Y, Kamei C (2009) Role of histamine H4 receptor in allergic conjunctivitis in mice. Eur J Pharmacol 608:71\u201375","journal-title":"Eur J Pharmacol"},{"key":"15_CR200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1358\/dot.2011.47.12.1709243","volume":"47","author":"R Namdar","year":"2011","unstructured":"Namdar R, Valdez C (2011) Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. Drugs Today 47:883\u2013890","journal-title":"Drugs Today"},{"key":"15_CR201","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-6749(83)90096-9","volume":"71","author":"SF Natbony","year":"1983","unstructured":"Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP (1983) Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 71:177\u2013183","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.2005.07049.x","volume":"154","author":"E Nettis","year":"2006","unstructured":"Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A (2006) Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol 154:533\u2013538","journal-title":"Br J Dermatol"},{"key":"15_CR203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/mol.59.3.427","volume":"59","author":"T Nguyen","year":"2001","unstructured":"Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (2001) Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59:427\u2013433","journal-title":"Mol Pharmacol"},{"key":"15_CR204","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2222.2003.01596.x","volume":"33","author":"MJ Noonan","year":"2003","unstructured":"Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B (2003) The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Clin Exp Allergy 33:351\u2013358","journal-title":"Clin Exp Allergy"},{"key":"15_CR205","first-page":"429","volume":"20","author":"PA O\u2019Leary","year":"1945","unstructured":"O\u2019Leary PA, Farber EM (1945) Benadryl in the treatment of urticaria. Proc Staff Meet Mayo Clin 20:429\u2013432","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"15_CR206","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","volume":"275","author":"T Oda","year":"2000","unstructured":"Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781\u201336786","journal-title":"J Biol Chem"},{"key":"15_CR207","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/0470034092.ch17","volume-title":"Immunogenomics and human disease","author":"N O'Donnell","year":"2006","unstructured":"O'Donnell N, Dunford PJ, Thurmond RL (2006) The histamine H4 receptor: drug discovery in the post-genomic era. In: Falus A (ed) Immunogenomics and human disease. Wiley, West Sussex, England, pp 395\u2013406"},{"key":"15_CR208","first-page":"436","volume":"61","author":"HD Oei","year":"1988","unstructured":"Oei HD (1988) Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Annals Allergy 61:436\u2013439","journal-title":"Annals Allergy"},{"key":"15_CR209","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1398-9995.2012.02854.x","volume":"67","author":"Y Ohsawa","year":"2012","unstructured":"Ohsawa Y, Hirasawa N (2012) The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC\/Nga mice. Allergy 67:1014\u20131022","journal-title":"Allergy"},{"key":"15_CR210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1081\/RRS-120014612","volume":"22","author":"M O'Reilly","year":"2002","unstructured":"O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, Fidock M (2002) Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct 22:431\u2013448","journal-title":"J Recept Signal Transduct"},{"key":"15_CR211","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/112067210201200402","volume":"12","author":"V Orfeo","year":"2002","unstructured":"Orfeo V, Vardaro A, Lena P, Mensitieri I, Tracey M, De Marco R (2002) Comparison of emedastine 0.05\u00a0% or nedocromil sodium 2\u00a0% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis. Eur J Ophthalmol 12:262\u2013266","journal-title":"Eur J Ophthalmol"},{"key":"15_CR212","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1517\/14656566.2011.629189","volume":"12","author":"JP Ortonne","year":"2011","unstructured":"Ortonne JP (2011) Chronic urticaria: a comparison of management guidelines. Expert Opin Pharmacother 12:2683\u20132693","journal-title":"Expert Opin Pharmacother"},{"key":"15_CR213","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00128071-200708010-00005","volume":"8","author":"JP Ortonne","year":"2007","unstructured":"Ortonne JP, Grob JJ, Auquier P, Dreyfus I (2007) Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 8:37\u201342","journal-title":"Am J Clin Dermatol"},{"key":"15_CR214","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrn3526","volume":"14","author":"P Panula","year":"2013","unstructured":"Panula P, Nuutinen S (2013) The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14:472\u2013487","journal-title":"Nat Rev Neurosci"},{"key":"15_CR215","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.neuroimage.2011.10.099","volume":"59","author":"ADP Papoiu","year":"2012","unstructured":"Papoiu ADP, Coghill RC, Kraft RA, Wang H, Yosipovitch G (2012) A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage 59:3611\u20133623","journal-title":"Neuroimage"},{"key":"15_CR216","first-page":"715","volume":"136","author":"J-J Parrot","year":"1942","unstructured":"Parrot J-J (1942) Les modifications aportees par un antagoniste de l'histamine (2,339 R.P.) a la reaction vasculaire locale de la peau. CR Seances Soc Biol Ses Fil 136:715\u2013716","journal-title":"CR Seances Soc Biol Ses Fil"},{"key":"15_CR217","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2003.00171.x","volume":"58","author":"PC Potter","year":"2003","unstructured":"Potter PC (2003) Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 58:893\u2013899","journal-title":"Allergy"},{"key":"15_CR218","first-page":"34","volume":"1","author":"F Pour-Reza-Gholi","year":"2007","unstructured":"Pour-Reza-Gholi F, Nasrollahi A, Firouzan A, Nasli Esfahani E, Farrokhi F (2007) Low-dose doxepin for treatment of pruritus in patients on hemodialysis. Iran J Kidney Dis 1:34\u201337","journal-title":"Iran J Kidney Dis"},{"key":"15_CR219","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","volume":"37","author":"RJ Powell","year":"2007","unstructured":"Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, Mirakian R, Walker SM, Huber PA, Nasser SM (2007) BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 37:631\u2013650","journal-title":"Clin Exp Allergy"},{"key":"15_CR220","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.107.120519","volume":"321","author":"H Preuss","year":"2007","unstructured":"Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R (2007) Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity. J Pharmacol Exp Ther 321:975\u2013982","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR221","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/ajrccm.149.6.8004306","volume":"149","author":"DG Raible","year":"1994","unstructured":"Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES (1994) Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med 149:1506\u20131511","journal-title":"Am J Respir Crit Care Med"},{"key":"15_CR222","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)61174-X","volume":"95","author":"PH Ratner","year":"2005","unstructured":"Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH (2005) Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95:474\u2013479","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR223","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)60408-5","volume":"100","author":"PH Ratner","year":"2008","unstructured":"Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H (2008) Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 100:74\u201381","journal-title":"Ann Allergy Asthma Immunol"},{"key":"15_CR224","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2222.1993.tb02487.x","volume":"23","author":"T Reunala","year":"1993","unstructured":"Reunala T, Brummer-Korvenkontio H, Karppinen A, Coulie P, Palosuo T (1993) Treatment of mosquito bites with cetirizine. Clin Exp Allergy 23:72\u201375","journal-title":"Clin Exp Allergy"},{"key":"15_CR225","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nn.3404","volume":"16","author":"DP Roberson","year":"2013","unstructured":"Roberson DP, Gudes S, Sprague JM, Patoski HAW, Robson VK, Blasl F, Duan B, Oh SB, Bean BP, Ma Q, Binshtok AM, Woolf CJ (2013) Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons. Nat Neurosci 16:910\u2013918","journal-title":"Nat Neurosci"},{"key":"15_CR226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-0625.2008.00762.x","volume":"18","author":"K Rossbach","year":"2009","unstructured":"Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, Kietzmann M, Baeumer W (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18:57\u201363","journal-title":"Exp Dermatol"},{"key":"15_CR227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2011.06.002","volume":"190","author":"K Rossbach","year":"2011","unstructured":"Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Baeumer W (2011) Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience 190:89\u2013102","journal-title":"Neuroscience"},{"key":"15_CR228","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1365-2133.2000.03535.x","volume":"142","author":"R Rukwied","year":"2000","unstructured":"Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M (2000) Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients. A dermal microdialysis study. Br J Dermatol 142:1114\u20131120","journal-title":"Br J Dermatol"},{"key":"15_CR229","first-page":"443","volume":"38","author":"GE Russo","year":"1986","unstructured":"Russo GE, Spaziani M, Guidotti C, Scarpellini MG, Leri O, Bonini S, Crisciotti C, Carmenini G (1986) Pruritus in chronic uremic patients in periodic hemodialysis. Treatment with terfenadine (an antagonist of histamine H1 receptors). Minerva Urol Nefrol 38:443\u2013447","journal-title":"Minerva Urol Nefrol"},{"key":"15_CR230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","volume":"36","author":"H Saeki","year":"2009","unstructured":"Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K (2009) Guidelines for management of atopic dermatitis. J Dermatol 36:563\u2013577","journal-title":"J Dermatol"},{"key":"15_CR231","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/gut.50.6.786","volume":"50","author":"T Saitoh","year":"2002","unstructured":"Saitoh T, Fukushima Y, Otsuka H, Ishikawa M, Tamai M, Takahashi H, Mori H, Asano T, Anai M, Ishikawa T, Katsube T, Ogawa K, Kajiwara T, Omata M, Ohkawa S (2002) Effects of N-alpha-methyl-histamine on human H2 receptors expressed in CHO cells. Gut 50:786\u2013789","journal-title":"Gut"},{"key":"15_CR232","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/82956","volume":"4","author":"M Schmelz","year":"2001","unstructured":"Schmelz M (2001) A neural pathway for itch. Nat Neurosci 4:9\u201310","journal-title":"Nat Neurosci"},{"key":"15_CR233","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","volume":"17","author":"M Schmelz","year":"1997","unstructured":"Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE (1997) Specific C-receptors for Itch in human skin. J Neurosci 17:8003\u20138008","journal-title":"J Neurosci"},{"key":"15_CR234","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1152\/jn.01139.2002","volume":"89","author":"M Schmelz","year":"2003","unstructured":"Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjoerk HE, Handwerker HO (2003) Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 89:2441\u20132448","journal-title":"J Neurophysiol"},{"key":"15_CR235","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejpain.2007.12.003","volume":"12","author":"G Schneider","year":"2008","unstructured":"Schneider G, Staender S, Burgmer M, Driesch G, Heuft G, Weckesser M (2008) Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain (Amsterdam, Netherland) 12:834\u2013841","journal-title":"Eur J Pain (Amsterdam, Netherland)"},{"key":"15_CR236","doi-asserted-by":"crossref","unstructured":"Schwartz JC (2009) Preclinical and clinical pharmacology of H3 receptor inverse agonist. In: 22nd ECNP congress p S.19.02, Istanbul, Turkey","DOI":"10.1016\/S0924-977X(09)70266-4"},{"key":"15_CR237","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0091-6749(82)90044-6","volume":"70","author":"C Secher","year":"1982","unstructured":"Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N (1982) Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol 70:211\u2013218","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR238","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/jpet.103.049619","volume":"305","author":"R Seifert","year":"2003","unstructured":"Seifert R, Wenzel-Seifert K, Burckstummer T, Pertz HH, Schunack W, Dove S, Buschauer A, Elz S (2003) Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor. J Pharmacol Exp Ther 305:1104\u20131115","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR239","first-page":"7","volume":"71B","author":"M Seike","year":"2007","unstructured":"Seike M, Furuya K (2007) Thioperamide (H3 and H4 receptor antagonist) improves ecezematous lesions in murine contact dermatitis. Sagami Joshi Daigaku Kiyo, Shizenkei 71B:7\u201313","journal-title":"Sagami Joshi Daigaku Kiyo, Shizenkei"},{"key":"15_CR240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1398-9995.2009.02240.x","volume":"65","author":"M Seike","year":"2010","unstructured":"Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H (2010) Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 65:319\u2013326","journal-title":"Allergy"},{"key":"15_CR241","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jop.1996.12.401","volume":"12","author":"NA Sharif","year":"1996","unstructured":"Sharif NA, Xu SX, Yanni JM (1996) Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long-acting, H1-selective histamine antagonist and antiallergic agent for use in allergic conjunctivitis. J Ocul Pharmacol Ther 12:401\u2013407","journal-title":"J Ocul Pharmacol Ther"},{"key":"15_CR242","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jid.1950.103","volume":"15","author":"WB Shelley","year":"1950","unstructured":"Shelley WB, Melton FM (1950) Relative effect of local anesthetics on experimental histamine pruritus in man. J Investig Dermatol 15:299\u2013300","journal-title":"J Investig Dermatol"},{"key":"15_CR243","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2273.1994.tb01146.x","volume":"19","author":"D Shelton","year":"1994","unstructured":"Shelton D, Eiser N (1994) Histamine receptors in the human nose. Clin Otolaryngol Allied Sci 19:45\u201349","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"15_CR244","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1523\/JNEUROSCI.4643-06.2007","volume":"27","author":"W-S Shim","year":"2007","unstructured":"Shim W-S, Tak M-H, Lee M-H, Kim M, Kim M, Koo J-Y, Lee C-H, Kim M, Oh U (2007) TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 27:2331\u20132337","journal-title":"J Neurosci"},{"key":"15_CR245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2011.11.027","volume":"675","author":"N Shin","year":"2012","unstructured":"Shin N, Covington M, Bian D, Zhuo J, Bowman K, Li Y, Soloviev M, Qian D-Q, Feldman P, Leffet L, He X, Wang KH, Krug K, Bell D, Czerniak P, Hu Z, Zhao H, Zhang J, Yeleswaram S, Yao W, Newton R, Scherle P (2012) INCB38579, a novel and potent histamine H4 receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 675:47\u201356","journal-title":"Eur J Pharmacol"},{"key":"15_CR246","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.1202049","volume":"190","author":"Y Shiraishi","year":"2013","unstructured":"Shiraishi Y, Jia Y, Domenico J, Joetham A, Karasuyama H, Takeda K, Gelfand EW (2013) Sequential engagement of Fc\u00ce\u03bcRI on mast cells and basophil histamine H4 receptor and FceRI in allergic rhinitis. J Immunol 190:539\u2013548","journal-title":"J Immunol"},{"key":"15_CR247","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","volume":"123","author":"F Siebenhaar","year":"2009","unstructured":"Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123:672\u2013679","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR248","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1152\/jn.00527.2003","volume":"91","author":"DA Simone","year":"2004","unstructured":"Simone DA, Zhang X, Li J, Zhang J-M, Honda CN, LaMotte RH, Giesler GJ Jr (2004) Comparison of responses of primate spinothalamic tract neurons to pruritic and algogenic stimuli. J Neurophysiol 91:213\u2013222","journal-title":"J Neurophysiol"},{"key":"15_CR249","first-page":"497","volume":"73","author":"RJ Simpson","year":"1994","unstructured":"Simpson RJ (1994) Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Annals Allergy 73:497\u2013502","journal-title":"Annals Allergy"},{"key":"15_CR250","first-page":"309","volume":"9","author":"T Sollmann","year":"1917","unstructured":"Sollmann T, Pilcher JD (1917) Endermic reactions. I. J Pharmacol 9:309\u2013340","journal-title":"J Pharmacol"},{"key":"15_CR251","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","volume":"117","author":"E Sonkoly","year":"2006","unstructured":"Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411\u2013417","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR252","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0149-2918(01)80106-5","volume":"23","author":"DL Spangler","year":"2001","unstructured":"Spangler DL, Bensch G, Berdy GJ (2001) Evaluation of the efficacy of olopatadine hydrochloride 0.1\u00a0% ophthalmic solution and azelastine hydrochloride 0.05\u00a0% ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 23:1272\u20131280","journal-title":"Clin Ther"},{"key":"15_CR253","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/S0149-2918(03)80217-5","volume":"25","author":"DL Spangler","year":"2003","unstructured":"Spangler DL, Abelson MB, Ober A, Gotnes PJ (2003) Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 25:2245\u20132267","journal-title":"Clin Ther"},{"key":"15_CR254","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","volume":"125","author":"M Staevska","year":"2010","unstructured":"Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, Church DS, Dimitrov V, Church MK (2010) The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 125:676\u2013682","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR255","first-page":"818","volume":"125","author":"AM Staub","year":"1937","unstructured":"Staub AM, Bovet D (1937) Action of thymoxyethyldiethylamine (F 929) and other phenol ethers on anaphylactic shock in guinea pigs. C R Seances Soc Biol Fil 125:818\u2013821","journal-title":"C R Seances Soc Biol Fil"},{"key":"15_CR256","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaci.2011.11.026","volume":"129","author":"JR Stokes","year":"2012","unstructured":"Stokes JR, Romero FA Jr, Allan RJ, Phillips PG, Hackman F, Misfeldt J, Casale TB (2012) The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. J Allergy Clin Immunol 129:409\u2013412.e402","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR257","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0091-6749(89)90450-8","volume":"83","author":"WW Storms","year":"1989","unstructured":"Storms WW, Bodman SF, Nathan RA, Chervinsky P, Banov CH, Dockhorn RJ, Jarmoszuk I, Zeitz HJ, McGeady SJ, Pinnas JL et al (1989) SCH 434: a new antihistamine\/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol 83:1083\u20131090","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR258","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.11.018","volume":"1250","author":"MI Strakhova","year":"2009","unstructured":"Strakhova MI, Nikkel AL, Manelli AM, Hsieh GC, Esbenshade TA, Brioni JD, Bitner RS (2009) Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 1250:41\u201348","journal-title":"Brain Res"},{"key":"15_CR259","doi-asserted-by":"crossref","unstructured":"Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong GSC, Krueger JG, Guttman-Yassky E (2013) Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol 132:361\u2013370","DOI":"10.1016\/j.jaci.2013.04.046"},{"key":"15_CR260","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2004.01876.x","volume":"34","author":"Y Sugimoto","year":"2004","unstructured":"Sugimoto Y, Iba Y, Nakamura Y, Kayasuga R, Kamei C (2004) Pruritus-associated response mediated by cutaneous histamine H3 receptors. Clin Exp Allergy 34:456\u2013459","journal-title":"Clin Exp Allergy"},{"key":"15_CR261","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejphar.2011.05.037","volume":"667","author":"E Suwa","year":"2011","unstructured":"Suwa E, Yamaura K, Oda M, Namiki T, Ueno K (2011) Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 667:383\u2013388","journal-title":"Eur J Pharmacol"},{"key":"15_CR262","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.intimp.2009.02.011","volume":"9","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C (2009) Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 9:734\u2013738","journal-title":"Int Immunopharmacol"},{"key":"15_CR263","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000110112","volume":"81","author":"T Tamura","year":"2008","unstructured":"Tamura T, Matsubara M, Amano T, Chida M (2008) Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function. Pharmacology 81:118\u2013126","journal-title":"Pharmacology"},{"key":"15_CR264","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000330663","volume":"158","author":"H Tanizaki","year":"2012","unstructured":"Tanizaki H, Ikoma A, Fukuoka M, Miyachi Y, Kabashima K (2012) Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. Int Arch Allergy Immunol 158:191\u2013195","journal-title":"Int Arch Allergy Immunol"},{"key":"15_CR265","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/09546634.2013.789472","volume":"24","author":"H Tanizaki","year":"2013","unstructured":"Tanizaki H, Nakahigashi K, Miyachi Y, Kabashima K (2013a) Comparison of the efficacy of fexofenadine 120 and 240\u00a0mg\/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. J Dermatolog Treat 24:477\u2013480","journal-title":"J Dermatolog Treat"},{"key":"15_CR266","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000353191","volume":"92","author":"H Tanizaki","year":"2013","unstructured":"Tanizaki H, Nakamizo S, Nakahigashi K, Miyachi Y, Kabashima K (2013b) A Double Dose of Levocetirizine Leads to Better Control of Histamine-Induced Flare, Wheal and Itch in Healthy Donors. Pharmacology 92:71\u201374","journal-title":"Pharmacology"},{"key":"15_CR267","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjp.0706118","volume":"144","author":"T Taylor-Clark","year":"2005","unstructured":"Taylor-Clark T, Sodha R, Warner B, Foreman J (2005) Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol 144:867\u2013874","journal-title":"Br J Pharmacol"},{"key":"15_CR268","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.103.061754","volume":"309","author":"RL Thurmond","year":"2004","unstructured":"Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung W-P, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309:404\u2013413","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.02.008","volume":"58","author":"Y Tokura","year":"2010","unstructured":"Tokura Y (2010) Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 58:1\u20137","journal-title":"J Dermatol Sci"},{"key":"15_CR270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2010.548797","volume":"27","author":"G Torkildsen","year":"2011","unstructured":"Torkildsen G, Shedden A (2011) The safety and efficacy of alcaftadine 0.25\u00a0% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Curr Med Res Opin 27:623\u2013631","journal-title":"Curr Med Res Opin"},{"key":"15_CR271","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1073\/pnas.75.12.6290","volume":"75","author":"VT Tran","year":"1978","unstructured":"Tran VT, Chang RS, Snyder SH (1978) Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. Proc Natl Acad Sci U S A 75:6290\u20136294","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR272","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-3565(25)25923-7","volume":"130","author":"U Trendelenburg","year":"1960","unstructured":"Trendelenburg U, Hobbs RD (1960) Action of histamine and 5-hydroxytryptamine (5-HT) on isolated mammalian atria. J Pharmacol Exp Ther 130:450\u2013460","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR273","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2005.08.045","volume":"522","author":"C Varga","year":"2005","unstructured":"Varga C, Horvath K, Berko A, Thurmond RL, Dunford PJ, Whittle BJR (2005) Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol 522:130\u2013138","journal-title":"Eur J Pharmacol"},{"key":"15_CR274","first-page":"339","volume":"56","author":"DY Wang","year":"2001","unstructured":"Wang DY, Hanotte F, De VC, Clement P (2001) Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers. Allergy (Copenhagen) 56:339\u2013343","journal-title":"Allergy (Copenhagen)"},{"key":"15_CR275","first-page":"117","volume":"60","author":"YH Wang","year":"2005","unstructured":"Wang YH, Tache Y, Harris AG, Kreutner W, Daly AF, Wei JY (2005) Desloratadine prevents compound 48\/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique. Allergy (Oxford, UK) 60:117\u2013124","journal-title":"Allergy (Oxford, UK)"},{"key":"15_CR276","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/11631990-000000000-00000","volume":"26","author":"RH Weisler","year":"2012","unstructured":"Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C (2012) Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder. CNS Drugs 26:421\u2013434","journal-title":"CNS Drugs"},{"key":"15_CR277","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s000110050213","volume":"46","author":"E Weisshaar","year":"1997","unstructured":"Weisshaar E, Ziethen B, Gollnick H (1997) Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res 46:412\u2013416","journal-title":"Inflamm Res"},{"key":"15_CR278","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0028-3908(02)00041-2","volume":"42","author":"P Wellendorph","year":"2002","unstructured":"Wellendorph P, Goodman MW, Burstein ES, Nash NR, Brann MR, Weiner DM (2002) Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology 42:929\u2013940","journal-title":"Neuropharmacology"},{"key":"15_CR279","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/jid.2009.134","volume":"129","author":"K Weller","year":"2009","unstructured":"Weller K, Maurer M (2009) Desloratadine inhibits human skin mast cell activation and histamine release. J Investig Dermatol 129:2723\u20132726","journal-title":"J Investig Dermatol"},{"key":"15_CR280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0149-2918(04)90003-3","volume":"26","author":"SM Whitcup","year":"2004","unstructured":"Whitcup SM, Bradford R, Lue J, Schiffman RM, Abelson MB (2004) Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis. Clin Ther 26:29\u201334","journal-title":"Clin Ther"},{"key":"15_CR281","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3565(24)29209-0","volume":"299","author":"K Wieland","year":"2001","unstructured":"Wieland K, Bongers G, Yamamoto Y, Hashimoto T, Yamatodani A, Menge WMBP, Timmerman H, Lovenberg TW, Leurs R (2001) Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. J Pharmacol Exp Ther 299:908\u2013914","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR282","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0016-5085(85)80141-4","volume":"88","author":"RH Wiesner","year":"1985","unstructured":"Wiesner RH, LaRusso NF, Ludwig J, Dickson ER (1985) Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108\u2013114","journal-title":"Gastroenterology"},{"key":"15_CR283","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","volume":"352","author":"HC Williams","year":"2005","unstructured":"Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314\u20132324","journal-title":"N Engl J Med"},{"key":"15_CR284","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1046\/j.1365-2745.2002.01509.x","volume":"32","author":"AM Wilson","year":"2002","unstructured":"Wilson AM, Haggart K, Sims EJ, Lipworth BJ (2002) Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy 32:1504\u20131509","journal-title":"Clin Exp Allergy"},{"key":"15_CR285","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cber.190704003164","volume":"40","author":"A Windaus","year":"1907","unstructured":"Windaus A, Vogt W (1907) Synthese des imidazolyl-athylamins. Ber Dtsch Chem Ges 40:3691\u20133695","journal-title":"Ber Dtsch Chem Ges"},{"key":"15_CR286","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2273.1996.tb01085.x","volume":"21","author":"R Wood-Baker","year":"1996","unstructured":"Wood-Baker R, Lau L, Howarth PH (1996) Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci 21:348\u2013352","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"15_CR287","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(02)02382-8","volume":"453","author":"BS Wulff","year":"2002","unstructured":"Wulff BS, Hastrup S, Rimvall K (2002) Characteristics of recombinantly expressed rat and human histamine H3 receptors. Eur J Pharmacol 453:33\u201341","journal-title":"Eur J Pharmacol"},{"key":"15_CR288","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0140-6736(72)92719-5","volume":"2","author":"JH Wyllie","year":"1972","unstructured":"Wyllie JH, Hesselbo T, Black JW (1972) Effects in man of histamine H2-receptor blockade by burimamide. Lancet 2:1117\u20131120","journal-title":"Lancet"},{"key":"15_CR289","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2131\/jts.34.427","volume":"34","author":"K Yamaura","year":"2009","unstructured":"Yamaura K, Oda M, Suwa E, Suzuki M, Sato H, Ueno K (2009) Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 34:427\u2013431","journal-title":"J Toxicol Sci"},{"key":"15_CR290","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1600-0420.2003.00079.x","volume":"81","author":"V Yaylali","year":"2003","unstructured":"Yaylali V, Demirlenk I, Tatlipinar S, Ozbay D, Esme A, Yildirim C, Ozden S (2003) Comparative study of 0.1\u00a0% olopatadine hydrochloride and 0.5\u00a0% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand 81:378\u2013382","journal-title":"Acta Ophthalmol Scand"},{"key":"15_CR291","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2133.2000.03829.x","volume":"143","author":"G Yosipovitch","year":"2000","unstructured":"Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL (2000) The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 143:969\u2013973","journal-title":"Br J Dermatol"},{"key":"15_CR292","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.0022-202X.2005.23942.x","volume":"125","author":"G Yosipovitch","year":"2005","unstructured":"Yosipovitch G, Fast K, Bernhard JD (2005) Noxious heat and scratching decrease histamine-induced itch and skin blood flow. J Investig Dermatol 125:1268\u20131272","journal-title":"J Investig Dermatol"},{"key":"15_CR293","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2133.2006.07711.x","volume":"156","author":"G Yosipovitch","year":"2007","unstructured":"Yosipovitch G, Duque MI, Fast K, Dawn AG, Coghill RC (2007) Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study. Br J Dermatol 156:629\u2013634","journal-title":"Br J Dermatol"},{"key":"15_CR294","first-page":"37","volume":"3","author":"F Yu","year":"2010","unstructured":"Yu F, Wolin RL, Wei J, Desai PJ, McGovern PM, Dunford PJ, Karlsson L, Thurmond RL (2010) Pharmacological characterization of oxime agonists of the histamine H4 receptor. J Recept Ligand Channel Res 3:37\u201349","journal-title":"J Recept Ligand Channel Res"},{"key":"15_CR295","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/mol.59.3.434","volume":"59","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, Herrity NC, Vawter L, Sarau HM, Ames RS, Davenport CM, Hieble JP, Wilson S, Bergsma DJ, Fitzgerald LR (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59:434\u2013441","journal-title":"Mol Pharmacol"},{"key":"15_CR296","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0190-9622(97)80275-7","volume":"36","author":"IM Zonneveld","year":"1997","unstructured":"Zonneveld IM, Meinardi MM, Karlsmark T, Johansen UB, Kuiters GR, Hamminga L, Staberg B, van't Veen AJ, Bossuyt PM, van Niel JC, Bos JD (1997) Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study. J Am Acad Dermatol 36:932\u2013934","journal-title":"J Am Acad Dermatol"},{"key":"15_CR297","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0091-6749(88)90969-4","volume":"82","author":"P Zuber","year":"1988","unstructured":"Zuber P, Pecoud A (1988) Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens. J Allergy Clin Immunol 82:590\u2013594","journal-title":"J Allergy Clin Immunol"},{"key":"15_CR298","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04185.x","volume":"26","author":"T Zuberbier","year":"2012","unstructured":"Zuberbier T (2012) Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses. J Eur Acad Dermatol Venereol 26:9\u201318","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"15_CR299","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-0240","volume":"87","author":"T Zuberbier","year":"2007","unstructured":"Zuberbier T, Maurer M (2007) Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 87:196\u2013205","journal-title":"Acta Derm Venereol"},{"key":"15_CR300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4419-8056-4_7","volume":"709","author":"T Zuberbier","year":"2010","unstructured":"Zuberbier T, Maurer M (2010) Antihistamines in the treatment of urticaria. Adv Exp Med Biol 709:67\u201372","journal-title":"Adv Exp Med Biol"},{"key":"15_CR301","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","volume":"64","author":"T Zuberbier","year":"2009","unstructured":"Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B (2009) EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria. Allergy 64:1427\u20131443","journal-title":"Allergy"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacology of Itch"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-662-44605-8_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:26:02Z","timestamp":1747873562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-662-44605-8_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783662446041","9783662446058"],"references-count":301,"URL":"https:\/\/doi.org\/10.1007\/978-3-662-44605-8_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-662-44605-8","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}